Itzhak Goldberg is Director of Angion Biomedica Corp.. Currently has a direct ownership of 1.69 Million shares of ANGN, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2022, when has been sold 32,082 shares (Common Stock) at a price of $1.12 per share, resulting in proceeds of $35,932. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.69M
0% 3M change
0% 12M change
Total Value Held $0

Itzhak Goldberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2022
SELL
Payment of exercise price or tax liability
$35,932 $1.12 p/Share
32,082 Reduced 1.87%
1,687,986 Common Stock
Dec 06 2021
SELL
Open market or private sale
$107,595 $3.35 p/Share
32,118 Reduced 1.83%
1,720,068 Common Stock
Dec 03 2021
SELL
Open market or private sale
$136,329 $3.39 p/Share
40,215 Reduced 2.24%
1,752,186 Common Stock
Dec 02 2021
SELL
Open market or private sale
$136,188 $3.51 p/Share
38,800 Reduced 2.12%
1,792,401 Common Stock
Dec 01 2021
SELL
Open market or private sale
$137,589 $3.54 p/Share
38,867 Reduced 2.08%
1,831,201 Common Stock
Nov 16 2021
SELL
Open market or private sale
$163,989 $4.26 p/Share
38,495 Reduced 2.02%
1,870,068 Common Stock
Nov 15 2021
SELL
Open market or private sale
$464,976 $4.17 p/Share
111,505 Reduced 5.52%
1,908,563 Common Stock
Jun 24 2021
SELL
Payment of exercise price or tax liability
$653,310 $13.78 p/Share
47,410 Reduced 2.29%
2,020,068 Common Stock
Feb 09 2021
SELL
Payment of exercise price or tax liability
$613,648 $16.0 p/Share
38,353 Reduced 1.82%
2,067,478 Common Stock
IG

Itzhak Goldberg

Director
Uniondale, NY

Track Institutional and Insider Activities on ANGN

Follow Angion Biomedica Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANGN shares.

Notify only if

Insider Trading

Get notified when an Angion Biomedica Corp. insider buys or sells ANGN shares.

Notify only if

News

Receive news related to Angion Biomedica Corp.

Track Activities on ANGN